-
Amino-terminal sequence of a large form of basic fibroblast growth factor isolated from human benign prostatic hyperplastic tissue.
Homogenization of human benign prostatic hyperplastic tissue in high ionic strength alkaline buffer containing protease inhibitors resulted in the isolation of a 17,400 molecular weight growth factor. When tissue was homogenized in ammonium sulfate at pH 4.5 without protease inhibitors a smaller, 16,600 dalton, growth factor was isolated. Both growth factors reacted with antisera against synthetic peptides whose sequences corresponded to the amino-terminal (1-12), Internal (33-43) and carboxyl-terminal (135-145) portions of basic fibroblast growth factor (bFGF). This suggested that the smaller growth factor was not a truncated form of (1-146) bFGF and that the larger growth factor may contain additional sequences. Amino-terminal sequencing showed the larger growth factor to have the sequence: Ala-Ala-Gly-Ser-Ile-Thr-Thr-Leu-Pro-Ala-Leu-Pro-Glu-Asp-Gly-Gly-Ser-Gly- Ala-Phe-Pro-. These results show that the larger growth factor is an 8 amino acid extended from of (1-146) bFGF and it is likely that the smaller growth factor is a proteolytic cleavage product of the larger growth factor produced during the extraction procedure.
PMID: 2435284 [PubMed - indexed for MEDLINE]
-
Cited by 3 PubMed Central articles
-
Prostatic carcinogenesis evoked by cellular interaction.
Chung LW, Chang SM, Bell C, Zhau H, Ro JY, von Eschenbach AC.
Environ Health Perspect. 1988 Apr; 77:23-8.
[Environ Health Perspect. 1988]
-
Effects of basic fibroblast growth factor on bone formation in vitro.
Canalis E, Centrella M, McCarthy T.
J Clin Invest. 1988 May; 81(5):1572-7.
[J Clin Invest. 1988]
-
High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons.
Prats H, Kaghad M, Prats AC, Klagsbrun M, Lélias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA.
Proc Natl Acad Sci U S A. 1989 Mar; 86(6):1836-40.
[Proc Natl Acad Sci U S A. 1989]